Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.19% Nasdaq Up 0.46%

Allergan Inc. (AGN)

-NYSE

86.61 Up 0.12(0.14%) Aug 17, 4:00PM EDT|After Hours: 86.71 Up 0.10 (0.12%) Aug 17, 4:31PM EDT

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2011Dec 30, 2010Dec 30, 2009
Total Revenue 5,419,100   4,919,400   4,503,600  
Cost of Revenue748,700  722,000  750,900  
Gross Profit 4,670,400   4,197,400   3,752,700  
Operating Expenses
Research Development902,800  804,600  706,000  
Selling General and Administrative2,246,600  2,017,600  1,921,500  
Non Recurring28,300  978,600  50,900  
Others127,600  138,000  146,300  
Total Operating Expenses3,305,300  3,938,800  2,824,700  
Operating Income or Loss 1,365,100   258,600   928,000  
Income from Continuing Operations
Total Other Income/Expenses Net6,400  (9,100)(2,600)
Earnings Before Interest And Taxes1,371,500  249,500  925,400  
Interest Expense71,800  78,700  76,900  
Income Before Tax1,299,700  170,800  848,500  
Income Tax Expense361,600  165,900  224,700  
Minority Interest(3,600)(4,300)(2,500)
Net Income From Continuing Ops934,500  600  621,300  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 934,500   600   621,300  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 934,500   600   621,300  

Currency in USD.